---
annotations:
- type: Pathway Ontology
  value: Leishmaniasis pathway
authors:
- ReactomeTeam
- DeSl
description: Macrophages specializing in tissue repair or associated with a Th2-type
  immune response are more permissive to infection with leishmania, since their defense
  mechanisms are not very efficient in eliminating the parasite and can contribute
  to its persistence (Lee et al. 2018).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9662851
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4993
- /instance/WP4993
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4993.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Macrophages specializing in tissue repair or associated with a Th2-type
    immune response are more permissive to infection with leishmania, since their
    defense mechanisms are not very efficient in eliminating the parasite and can
    contribute to its persistence (Lee et al. 2018).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9662851
    Reactome].
  keywords:
  - 'IGLC3 '
  - 'RAMP2 '
  - 'ADCY8 '
  - IgG:Lma
  - 'INSL3(21-55) '
  - 'IGLV2-23(1-?) '
  - PKA tetramer
  - CALM1:4xCa2+
  - 'PTH '
  - 'ADR '
  - 'Ig kappa chain V-I region BAN '
  - 'IGHV1-2 '
  - ADAM17(215-827)
  - (z):GTP:Adenylate
  - complexes that
  - G-protein beta-gamma
  - 'FYN '
  - 'IGLV8-61(1-?) '
  - 'Ig heavy chain V-II region MCE '
  - 'FSHR '
  - 'RLN2(25-53) '
  - p-S133-CREB1:IL10
  - 'GGT5(1-387) '
  - LTC4
  - Glucocorticoid, IL6,
  - 'GTP '
  - 'Ig lambda chain V-II region MGC '
  - 'Ig kappa chain V-I region AG '
  - GTP
  - ITPR:I(1,4,5)P3
  - 'IGHV(1-?) '
  - 'IGLV3-27(1-?) '
  - 'AVPR2 '
  - 'CALCRL '
  - 'IGLV(23-?) '
  - 'p-6Y-CD247 '
  - 'IGLV5-37(1-?) '
  - 'CRHR2 '
  - 'DPEP1 '
  - 'LCHA '
  - 'IGHG3 '
  - 'Ig lambda chain V-VI region AR '
  - 'RXFP1 '
  - I(1,4,5)P3
  - PLK2, MAPK14
  - 'Ig kappa chain V-II region Cum '
  - cAMP:PKA regulatory
  - 'ADM2(19-153) '
  - 'ADORA2B '
  - 'Ig heavy chain V-III region BUT '
  - 'FSHB '
  - 'CALCB(82-118) '
  - p-S,T-ADAM17(215-827):Zn2+
  - 'GNAI1 '
  - Src family kinases
  - 'IL6 '
  - surface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCG
  - 'IL10 gene '
  - 'IGLV3-22(1-?) '
  - 'GHRH '
  - 'HTR6 '
  - antigens:FCGR3A:p-CD3 dimers
  - '5HT '
  - p-PLCG
  - 'IGHV7-81(1-?) '
  - 'IGLC6 '
  - 'Mg2+ '
  - 'ADRB3 '
  - IL6
  - 'GPR39 '
  - 'IGKV4-1(21-?) '
  - p-S133-CREB1:IL6
  - 'IGLV1-44(1-?) '
  - IL10 gene
  - p-S133-CREB1
  - 'MYH9 '
  - 'GPHA2 '
  - 'GNG4 '
  - 'ADCY1 '
  - 'INSL3(106-131) '
  - 'ADCY7 '
  - Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDP
  - 'IGLV4-69(1-?) '
  - 'PLCG2 '
  - 'PTHLH '
  - 'Ca2+ '
  - Gly
  - 'glucocorticoid '
  - 'Ig heavy chain V-III region KOL '
  - 'Ig kappa chain V region EV15 '
  - 'IGHG2 '
  - cyclase
  - 'GNB5 '
  - FURIN
  - Gs:Heterotrimeric
  - PRKACA,(PRKACB,PRKACG,PRKX)
  - 'GNGT2 '
  - 'GNG2 '
  - catalytic subunits
  - 'IAPP(34-70) '
  - 'Ig lambda chain V region 4A '
  - 'Ig heavy chain V-I region EU '
  - LPG1G2
  - 'CD247-1 '
  - LTE4
  - iRHOM2
  - 'IGLV10-54(1-?) '
  - 'IGLV7-43(1-?) '
  - 'PLK2 '
  - antigens:FCGR3A:p-CD3 dimers:p-6Y-SYK
  - cAMP
  - DAGs
  - 'HCK '
  - DPEP1,2,3 dimers
  - 'FCGR1A '
  - 'MC2R '
  - 'NPSR1 '
  - 'p-Y753,Y759,Y1217-PLCG2 '
  - 'GNGT1 '
  - 'DPEP3 '
  - 'Ig heavy chain V-III region CAM '
  - 'Ig kappa chain V-III region VG '
  - clustered
  - 'Ig heavy chain V-II region NEWM '
  - 'IGKV1-12 '
  - 'RLN3(119-142) '
  - 'CD3G '
  - 'PTH2R '
  - 'Ig kappa chain V-II region FR '
  - PI(4,5)P2
  - 'GCG(53-81) '
  - 'CGA '
  - 'ITPR3 '
  - 'ADCY3 '
  - 'Ig heavy chain V-III region WEA '
  - gene
  - 'FCGR3A '
  - 'POMC(77-87) '
  - 'Ig lambda chain V-I region VOR '
  - (Mg2+ cofactor)
  - surface:p-FCGR3As:p-6Y-SYK:PLCG
  - 'TAAR5 '
  - ADORA2B:Ade-Rib
  - activate
  - 'SCTR '
  - 'TSHB '
  - 'IGLV2-11(1-?) '
  - 'DA '
  - (inactive)
  - subunit
  - 'PI(3,4,5)P3 '
  - 'PLCG1 '
  - 'IGLV1-36(1-?) '
  - 'Ig lambda chain V-IV region Bau '
  - 'p-Y288,Y304-FCGR2A '
  - 'IL10 '
  - 'GNB3 '
  - 'GNAZ '
  - 'PRKACG '
  - 'Ig heavy chain V-I region HG3 '
  - 'PTH2(62-100) '
  - 'ArgN-GCG(98-127) '
  - 'IGKVA18(21-?) '
  - 'Ig lambda chain V-II region BOH '
  - 'Ig heavy chain V-II region WAH '
  - G alpha
  - 'PRKAR1A '
  - 'GNB1 '
  - 'SYK '
  - 'Ig lambda chain V-I region NEWM '
  - 'Ig kappa chain V-I region AU '
  - AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramer
  - 'HRH2 '
  - 'POMC(217-234) '
  - 'Hist '
  - 'RAMP3 '
  - 'GNG10 '
  - 'ADCY9 '
  - 'IGLC2 '
  - complex
  - 'IGHG1 '
  - 'MC5R '
  - IL6 gene
  - 'IGKV2D-30 '
  - 'DCA '
  - GGT1, 5 dimers
  - LTD4
  - 'ADCYAP1(82-129) '
  - 'PGI2 '
  - IgG:Lma amastigote
  - 'IGHG4 '
  - IL10
  - 'GNG3 '
  - 'GNB2 '
  - 'RLN2(162-185) '
  - 'LHCGR '
  - 'TAAR8 '
  - 'ATP '
  - 'Ig heavy chain V-II region OU '
  - H2O
  - (i):GTP:Adenylate
  - 'AVP(20-28) '
  - 'CRHR1 '
  - 'p-6Y-SYK '
  - 'GLP-1 (7-37) '
  - IgG:Leishmania
  - 'RLN3(26-52) '
  - FCGRIIIA:CD3G/CD3Z
  - 'IGLV2-18(1-?) '
  - 'GNB4 '
  - 'LPG1G2 '
  - G-protein Gs
  - 'DRD1 '
  - 'IGLV1-40(1-?) '
  - 'VIPR2 '
  - 'ADM(95-146) '
  - 'IGLV3-25(1-?) '
  - 'TAAR3 '
  - ADAM17(215-827):Zn2+
  - PKA catalytic
  - 'IL6 gene '
  - Heterotrimeric
  - Protein Kinase A,
  - IgG:Lma antigens
  - 'Ig heavy chain V-III region BRO '
  - 'p-4Y-PLCG1 '
  - 'GPHB5 '
  - 'IGLV3-16(1-?) '
  - 'SRC-1 '
  - 'Ig kappa chain V-I region Daudi '
  - (s):GTP:Adenylate
  - 'DPEP2 '
  - 'ADCY5 '
  - 'GNAI3 '
  - 'POMC(138-150) '
  - 'Ig heavy chain V-III region JON '
  - 'GLP2R '
  - 'NAd '
  - Ade-Rib
  - 'ADCYAP1(132-169) '
  - GDP
  - 'GGT1(381-569) '
  - 'Lma amastigote surface '
  - 'PGD2 '
  - homotetramer
  - 'CALCA(83-119) '
  - 'PRKAR1B '
  - 'ITPR1 '
  - 'MC1R '
  - 'IGKV3D-20 '
  - 'Ig lambda chain V-IV region Kern '
  - 'MC3R(1-360) '
  - 'PTH1R '
  - 'PTGER2 '
  - ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTP
  - CYSLTR1,CYSLTR2
  - 'Ig lambda chain V-III region SH '
  - 'P2RY11 '
  - 'GHRHR '
  - 'LHB '
  - SYK
  - 'RAMP1 '
  - 'PTGIR '
  - antigens:FCGR3A:CD3
  - ADAM17(1-214)
  - 'GIPR '
  - 'PTGDR '
  - 'GCG(146-178) '
  - 'TAAR9 '
  - 'LYN '
  - 'NPS '
  - Adenylate cyclase
  - 'IGKV2-28 '
  - Ca2+
  - 'CDCA '
  - MYH9
  - 'IgH  heavy chain V-III region VH26 precursor '
  - PLC gamma1,2
  - 'CRH '
  - 'PRKAR2A '
  - IgG:LPG1G2
  - 'POMC(138-176) '
  - 'Ig kappa chain V-I region HK101 '
  - 'Ade-Rib '
  - G-protein alpha
  - 'ADORA2A '
  - 'PEA '
  - 'LTC4 '
  - 'Ig heavy chain V-III region TRO '
  - 'Ig kappa chain V-II region RPMI 6410 '
  - 'GNAT3 '
  - tetramer
  - 'ADRB1 '
  - 'IGLC1 '
  - 'PRKACB '
  - 'ITPR2 '
  - 'GNG5 '
  - 'cAMP '
  - 'PRKAR2B '
  - 'PGE2 '
  - 'sCD163 '
  - 'GGT1(1-380) '
  - 'GNG12 '
  - 'CYSLTR2 '
  - 'IGLV3-12(1-?) '
  - CALM1
  - 'YES1 '
  - 'GNG13 '
  - 'IGKV1-5(23-?) '
  - GGT1 dimer
  - CD163 gene
  - 'TAAR6 '
  - 'MC4R '
  - IgG-Ag:p-FCGRs:p-6Y-SYK:PLCG
  - 'Ig heavy chain V-III region DOB '
  - 'GLP1R '
  - sCD163
  - 'TAAR1 '
  - 'DRD5 '
  - 'ADCY6 '
  - CD163(1051-1156)
  - 'ADAM17(215-827) '
  - ADP
  - IgG
  - 'IGLV4-3(1-?) '
  - ADAM17
  - 'ADCYAP1R1 '
  - 'IGLV2-33(1-?) '
  - 'CALM1 '
  - PKA tetramer:4xcAMP
  - 'GGT5(388-586) '
  - 'VIPR1 '
  - IP3 receptor
  - 'Ig kappa chain V-III region POM '
  - 'GNG11 '
  - ADORA2B
  - 'Ig lambda chain V-I region HA '
  - sCD163:MYH9
  - 'Ig lambda chain V-I region NEW '
  - 'GNG7 '
  - 'FGR '
  - 'IGLV7-46(1-?) '
  - 'ADCY4 '
  - 'GNAI2 '
  - 'IGLV4-60(1-?) '
  - Ligand:GPCR
  - 'IGLV11-55(1-?) '
  - L-Glu
  - 'p-S133-CREB1 '
  - 'p-Y160,Y171-CD3G '
  - 'GNAS2 '
  - CREB1
  - Lma amastigote
  - 'GNAS1 '
  - PI(3,4,5)P3
  - 'Ig kappa chain V-I region DEE '
  - LTC4:CyslTR1,2
  - G alpha (s):GTP
  - 'Ig lambda chain V-II region TOG '
  - 'IGLC7 '
  - G-betagamma
  - 'GNG8 '
  - 'CALCR '
  - 'CCA '
  - 'VIP(125-152) '
  - 'p-T180,Y182-MAPK14 '
  - 'Ig lambda chain V-II region NEI '
  - 'GIP(52-93) '
  - 'Ig lambda chain V-III region LOI '
  - 'NAD+ '
  - 'ADCYAP1(132-158) '
  - Zn2+
  - 'ADRB2 '
  - 'Constitutively active orphan GPCRs '
  - 'AHCYL1 '
  - 'Ig kappa chain V-I region Gal '
  - surface
  - CD163
  - 'Zn2+ '
  - 'Ig lambda chain V-IV region Hil '
  - (SFKs)
  - 'CYSLTR1 '
  - PPi
  - 'Ig heavy chain V-II region ARH-77 '
  - 'ADCY2 '
  - 'HTR4 '
  - 'GDP '
  - 'GPBAR1 '
  - 'PRKX '
  - 'IGKC '
  - 'SCT '
  - 'PTGER4 '
  - dimers
  - 'Ig kappa chain V-I region Wes '
  - 'I(1,4,5)P3 '
  - 'TSHR '
  - ATP
  - 'PRKACA '
  - 'Ig kappa chain V-III region B6 '
  - 'TAAR2 '
  - 'RXFP2 '
  - 'HTR7 '
  - antigens:FCGR3A:p-CD3 dimers:SYK
  - 'IGLV5-45(1-?) '
  - 'Antigen '
  license: CC0
  name: Anti-inflammatory response favouring Leishmania parasite infection
seo: CreativeWork
title: Anti-inflammatory response favouring Leishmania parasite infection
wpid: WP4993
---